Dr Natalie Mills
Senior Lecturer
School of Medicine
College of Health
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Natalie is a Psychiatrist at the University of Adelaide, Discipline of Psychiatry. Her PhD investigated the role of cytokines and inflammatory markers in depression in adolescents.
Natalie is a Child and Adolescent Psychiatrist. She completed her PhD in November 2016, through The University of Queensland. Natalie's PhD investigated the role of cytokines and inflammatory markers in depression in adolescents. This work examined the phenotypic and genetic relationship between inflammatory markers and depression.
Project 1:
Title: Investigating the longitudinal relationship between inflammatory markers and anxiety disorders
Description: The project examines the phenotypic and genetic relationship between inflammatory markers and anxiety-based disorders
Location: University of Adelaide, Adelaide Health and Medical Sciences building
| Date | Position | Institution name |
|---|---|---|
| 2016 - ongoing | Senior Lecturer in Psychiatry | University of Adelaide |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2016 | The University of Queensland | Australia | PhD |
| 1993 | Monash University | Australia | MBBS |
| Date | Title | Institution | Country |
|---|---|---|---|
| 2009 - 2011 | Certificate of Advanced Training in Child and Adolescent Psychiatry | Royal Australian and New Zealand College of Psychiatrists | Australia |
| 2005 - 2005 | Diploma in Clinical Psychiatry | Royal College of Physicians of Ireland and Royal College of Surgeons in Ireland | Ireland |
| 2004 - 2010 | FRANZCP | Royal Australian and New Zealand College of Psychiatrists | Australia |
| 1996 - 2000 | FRACGP | Royal Australian College of General Practitioners, East Melbourne | Australia |
| Year | Citation |
|---|---|
| 2025 | Kamath, S., Sokolenko, E., Collins, K., Chan, N. S. L., Mills, N., Clark, S. R., . . . Joyce, P. (2025). IUPHAR Themed Review: The Gut Microbiome in Schizophrenia.. Pharmacological Research, 211(107561), 107561-1-107561-13. Scopus16 WoS15 Europe PMC12 |
| 2025 | Mills, N. T., Nikolin, S., Glozier, N., Barton, D., Baune, B. T., Fitzgerald, P. B., . . . Loo, C. K. (2025). Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study. British Journal of Psychiatry, 227(3), 601-607. Scopus1 |
| 2025 | Davies, E., Mills, N., Montagu, A., Chur-Hansen, A., & Clark, S. (2025). Hybrid simulation and immersive, lived-experience perspectives to shape medical student attitudes towards patients experiencing emotional distress, suicidality, and self-harm. Advances in Simulation, 10(1), 12 pages. Scopus2 WoS2 Europe PMC1 |
| 2025 | Amente, L. D., Mills, N. T., Le, T. D., Hyppönen, E., & Lee, S. H. (2025). A latent outcome variable approach for Mendelian randomization using the stochastic expectation maximization algorithm. Human Genetics, 144(5), 559-574. Scopus1 WoS1 Europe PMC1 |
| 2025 | Chatterton, M. L., Perez, J. K., Thai, T., Faller, J., Loo, C. K., Glozier, N., . . . Mihalopoulos, C. (2025). Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS study. Journal of Affective Disorders, 387, 119502-1-119502-10. Scopus2 WoS1 Europe PMC1 |
| 2025 | Loo, C., Alonzo, A., Barton, D., Berk, M., Chatterton, M. L., Dong, V., . . . Rodgers, A. (2025). Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): Randomised double-blind active-controlled trial: Commentary, author response. The British Journal of Psychiatry, 226(5), 317-318. |
| 2025 | Davis, K. A. S., Mirza, L., Clark, S. R., Coleman, J. R. I., Kassam, A. S., Mills, N. T., . . . Hotopf, M. (2025). Unlocking mental health insights with UK Biobank data: Past use and future opportunities.. Psychol Med, 55, e244. |
| 2025 | Amente, L. D., Mills, N. T., Le, T. D., Hypponen, E., & Lee, S. H. (2025). Disentangling horizontal and vertical Pleiotropy in genetic correlation estimation: introducing the HVP model. Human Genetics, 144(8), 861-876. Europe PMC1 |
| 2024 | Sampson, E., Mills, N. T., Hori, H., Cearns, M., Schwarte, K., Hohoff, C., . . . Baune, B. T. (2024). Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placebo.. Brain, behavior, and immunity, 123, S0889-1591(24)00597-X. Scopus5 WoS7 Europe PMC6 |
| 2024 | Loo, C., Glozier, N., Barton, D., Baune, B. T., Mills, N. T., Fitzgerald, P., . . . Rodgers, A. (2024). Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM. British Journal of Psychiatry the Journal of Mental Science, 225(2), 349. Scopus1 Europe PMC1 |
| 2024 | Amente, L. D., Mills, N. T., Le, T. D., Hyppönen, E., & Lee, S. H. (2024). Unraveling phenotypic variance in metabolic syndrome through multi-omics. Human Genetics, 143(1), 35-47. Scopus4 WoS4 Europe PMC2 |
| 2024 | Martin, D. M., Harvey, A. J., Baune, B., Berk, M., Carter, G. L., Dong, V., . . . Loo, C. K. (2024). Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS). Journal of affective disorders, 352, 163-170. Scopus8 WoS7 Europe PMC6 |
| 2024 | Sampson, E., Kavakbasi, E., Mills, N. T., Hori, H., Schubert, K. O., Fourrier, C., & Baune, B. T. (2024). Emotional blunting in depression in the PREDDICT clinical trial: inflammation-stratified augmentation of vortioxetine with celecoxib.. The international journal of neuropsychopharmacology, 27(3), pyad066. Scopus2 WoS3 Europe PMC2 |
| 2023 | Kavakbasi, E., Emma, S., Mills, N. T., Hori, H., Schwarte, K., Hohoff, C., . . . Baune, B. T. (2023). Inflammation-stratified augmentation of vortioxetine with celecoxib: results from a double-blind, randomized, placebo-controlled trial in Major Depressive Disorder. Journal of Neurochemistry, 168(9), 1817-1825. Scopus5 WoS8 Europe PMC4 |
| 2023 | Sampson, E., Mills, N. T., Hori, H., Schwarte, K., Hohoff, C., Schubert, O., . . . Baune, B. T. (2023). Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.. The Journal of clinical psychiatry, 84(6), 23m14829. Scopus4 WoS2 Europe PMC1 |
| 2023 | Loo, C., Glozier, N., Barton, D., Baune, B., Mills, N., Fitzgerald, P. B., . . . Rodgers, A. (2023). Efficacy and Safety of Repeated Subcutaneous Ketamine Injections for Treatment Resistant Depression - The KADS Study: A Randomised, Double-Blind, Comparator-Controlled Trial. British Journal of Psychiatry, 223(6), 533-541. Scopus55 WoS54 Europe PMC48 |
| 2022 | Baune, B. T., Sampson, E., Louise, J., Hori, H., Schubert, K. O., Clark, S. R., . . . Fourrier, C. (2022). Corrigendum to 'No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial' [European Neuropsychopharmacology 53 (2021) 34-46].. Eur Neuropsychopharmacol, 64, 61-62. |
| 2022 | Ciobanu, L. G., Stankov, L., Schubert, K. O., Amare, A. T., Jawahar, M. C., Lawrence-Wood, E., . . . Aidman, E. (2022). General intelligence and executive functioning are overlapping but separable at genetic and molecular pathway levels: An analytical review of existing GWAS findings. PLOS ONE, 17(10), e0272368. Scopus4 WoS3 Europe PMC3 |
| 2022 | Thalamuthu, A., Mills, N. T., Berger, K., Minnerup, H., Grotegerd, D., Dannlowski, U., . . . Baune, B. T. (2022). Genome-wide interaction study with major depression identifies novel variants associated with cognitive function.. Mol Psychiatry, 27(2), 1111-1119. Scopus41 WoS39 Europe PMC36 |
| 2021 | Enticott, P. G., Barlow, K., Guastella, A. J., Licari, M. K., Rogasch, N. C., Middeldorp, C. M., . . . Fitzgerald, P. B. (2021). Repetitive transcranial magnetic stimulation (rTMS) in autism spectrum disorder: protocol for a multicentre randomised controlled clinical trial. BMJ Open, 11(7), e046830-1-e046830-9. Scopus18 WoS16 Europe PMC13 |
| 2021 | Baune, B. T., Sampson, E., Louise, J., Hori, H., Schubert, K. O., Clark, S. R., . . . Fourrier, C. (2021). No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial.. Eur Neuropsychopharmacol, 53, 34-46. Scopus47 WoS47 Europe PMC44 |
| 2021 | Mills, N. T., Sampson, E., Fourrier, C., & Baune, B. T. (2021). Clinical switching strategies of various antidepressants to Vortioxetine in the PREDDICT trial. The international journal of neuropsychopharmacology, 24(4), 314-321. Scopus5 WoS6 Europe PMC3 |
| 2020 | Fourrier, C., Sampson, E., Hori, H., Schubert, K. O., Clark, S., Mills, N. T., & Baune, B. T. (2020). Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index status. Brain, Behavior, and Immunity, 88, 242-251. Scopus11 WoS12 Europe PMC12 |
| 2020 | Parsons, C., Roberts, R., & Mills, N. T. (2020). Review: Inflammation and anxiety-based disorders in children and adolescents - a systematic review and meta-analysis.. Child and adolescent mental health, 26(2), 143-156. Scopus20 WoS22 Europe PMC20 |
| 2019 | Knight, M. J., Mills, N. T., & Baune, B. T. (2019). Contemporary methods of improving cognitive dysfunction in clinical depression.. Expert review of neurotherapeutics, 19(5), 431-443. Scopus16 WoS11 Europe PMC8 |
| 2019 | Ni, G., Amare, A. T., Zhou, X., Mills, N., Gratten, J., & Lee, S. H. (2019). The genetic relationship between female reproductive traits and six psychiatric disorders. Scientific Reports, 9(1), 12041-1-12041-12. Scopus25 WoS22 Europe PMC21 |
| 2019 | Knight, M. J., Fourrier, C., Lyrtzis, E., Aboustate, N., Sampson, E., Hori, H., . . . Baune, B. T. (2019). Cognitive deficits in the THINC-integrated tool (THINC-it) are associated with psychosocial dysfunction in patients with major depressive disorder. Journal of Clinical Psychiatry, 80(1), 18m12472-1-18m12472-8. Scopus19 WoS15 Europe PMC14 |
| 2018 | Ni, G., Amare, A., Zhou, X., Mills, N., Gratten, J., & Hong Lee, S. (2018). The genetic relationship between female reproductive traits and six psychiatric disorders. |
| 2018 | Fourrier, C., Sampson, E., Mills, N. T., & Baune, B. T. (2018). Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo. Trials, 19(1), 447-1-447-14. Scopus59 WoS55 Europe PMC48 |
| 2018 | Van der Auwera, S., Peyrot, W., Milaneschi, Y., Hertel, J., Baune, B., Breen, G., . . . Grabe, H. (2018). Genome-wide gene-environment interaction in depression: a systematic evaluation of candidate genes: the childhood trauma working-group of PGC-MDD. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 177(1), 40-49. Scopus62 WoS53 Europe PMC44 |
| 2018 | Couvy-Duchesne, B., O'Callaghan, V., Parker, R., Mills, N., Kirk, K., Scott, J., . . . Gillespie, N. (2018). Nineteen and Up study (19Up): understanding pathways to mental health disorders in young Australian twins. BMJ open, 8(3), 1-12. Scopus28 WoS25 Europe PMC21 |
| 2018 | Cambridge, O., Knight, M., Mills, N., & Baune, B. (2018). The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: A systematic review. Psychiatry Research, 269, 157-171. Scopus149 WoS139 Europe PMC108 |
| 2017 | Renteria, M., Schmaal, L., Hibar, D., Couvy-Duchesne, B., Strike, L., Mills, N., . . . Hickie, I. (2017). Subcortical brain structure and suicidal behaviour in major depressive disorder: a meta-analysis from the ENIGMA-MDD working group. Translational Psychiatry, 7(5), e1116-1-e1116-7. Scopus81 WoS77 Europe PMC77 |
| 2017 | Schmaal, L., Hibar, D. P., Sämann, P. G., Hall, G. B., Baune, B. T., Jahanshad, N., . . . Veltman, D. J. (2017). Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Molecular Psychiatry, 22(6), 10 pages. Scopus985 WoS923 Europe PMC913 |
| 2017 | Mills, N., Maier, R., Whitfield, J., Wright, M., Colodro-Conde, L., Byrne, E., . . . Benyamin, B. (2017). Investigating the relationship between iron and depression. Journal of Psychiatric Research, 94, 148-155. Scopus15 WoS11 Europe PMC12 |
| 2016 | Schmaal, L., Veltman, D., van Erp, T., Saemann, P., Frodl, T., Jahanshad, N., . . . Hibar, D. (2016). Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. MOLECULAR PSYCHIATRY, 21(6), 806-812. Scopus894 WoS358 Europe PMC846 |
| 2015 | Mills, N. T., Wright, M. J., Henders, A. K., Eyles, D. W., Baune, B. T., McGrath, J. J., . . . Vinkhuyzen, A. A. E. (2015). Heritability of transforming growth factor-β1 and tumor necrosis factor-receptor type 1 expression and vitamin D levels in healthy adolescent twins. Twin Research and Human Genetics, 18(1), 28-35. Scopus21 WoS19 Europe PMC19 |
| 2013 | Mills, N., Scott, J., Wray, N., Cohen-Woods, S., & Baune, B. (2013). Research review: the role of cytokines in depression in adolescents: a systematic review. Journal of Child Psychology and Psychiatry and Allied Disciplines, 54(8), 816-835. Scopus86 WoS78 Europe PMC68 |
| Year | Citation |
|---|---|
| 2025 | Loo, C., Glozier, N., Barton, D., Baune, B., Mills, N., Fitzgerald, P., . . . Rodgers, A. (2025). EXTENDING KNOWLEDGE AND CLINICAL EXPERIENCE ON THE USE OF KETAMINE. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 59 (pp. 1 page). SAGE PUBLICATIONS LTD. |
| 2025 | Mills, N., Nikolin, S., Glozier, N., Barton, D., Baune, B., Fitzgerald, P., . . . Loo, C. (2025). EFFECT OF KETAMINE ON ANXIETY: FINDINGS FROM THE KETAMINE FOR ADULT DEPRESSION STUDY (KADS). In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 59 (pp. 1 page). SAGE PUBLICATIONS LTD. |
| 2024 | Mills, N., Parsons, C., Sharkey, D., Erginbas, A., Roberts, R., Scott, J., . . . Jawahar, M. (2024). INVESTIGATING THE RELATIONSHIP BETWEEN PERIPHERAL INFLAMMATORY MARKERS AND ANXIETY DISORDERS. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 58 (pp. 174-175). SAGE PUBLICATIONS LTD. |
| 2022 | Clark, S. R., Mills, N., Toben, C., Jawaha, C., & Galletly, C. (2022). MENTAL HEALTH MEDICAL EDUCATION LEAD: UNIVERSITY OF ADELAIDE, ADELAIDE - EVALUATING TECHNOLOGICAL SOLUTIONS TO MENTAL HEALTH TEACHING AND ASSESSMENT DURING THE PANDEMIC. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 56 (pp. 150). SAGE PUBLICATIONS LTD. |
| 2022 | Turner, M., Nasti, J., & Mills, N. (2022). AUSTRALASIAN PSYCHOPHARMACOLOGY INTEREST GROUP: 2022 UPDATE - NEW AND OLD MEDICATIONS: WHERE ARE WE UP TO?. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 56 (pp. 80-81). SAGE PUBLICATIONS LTD. |
| 2015 | Schmaal, L., Veltman, D. J., van Erp, T. G. M., Penninx, B. W. J. H., Thompson, P. M., & Hibar, D. P. (2015). Subcortical Brain Alterations in Major Depressive Disorder: Findings from the ENIGMA Major Depressive Disorder Working Group. In BIOLOGICAL PSYCHIATRY Vol. 77 (pp. 1 page). Toronto, CANADA: ELSEVIER SCIENCE INC. WoS518 |
| 2015 | Schmaal, L., Veltman, D. J., Van Erp, T. G., Saemann, P. G., Frodl, T., Jahanshad, N., . . . Hibar, D. P. (2015). Structural brain alterations in major depression: findings from the ENIGMA Major Depressive Disorder Working Group. In EUROPEAN NEUROPSYCHOPHARMACOLOGY Vol. 25 (pp. S394-S395). Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV. DOI WoS1 |
| Year | Citation |
|---|---|
| 2024 | Martin, D., Harvey, A., Baune, B., Berk, M., Carter, G., Dong, V., . . . Loo, C. (2024). Cognitive Outcomes Following a Course of Racemic Ketamine: Results From the Randomised, Active-Controlled Ketamine for Adult Depression Study (KADS). Poster session presented at the meeting of Abstracts of the 79th Annual Meeting of the Society of Biological Psychiatry (SOBP 2024) as published in Biological Psychiatry. Austin, Texas, USA: Elsevier. DOI |
| 2021 | Turner, M., Kotze, B., & Mills, N. (2021). PSYCHOPHARMACOLOGY UPDATE: RECENT ADVANCES FOR CHILDREN AND ADOLESCENTS AND IMPLICATIONS FOR PRACTICE. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. SAGE PUBLICATIONS LTD. |
| 2021 | Ciobanu, L., Stankov, L., Heathcote, A., Clark, S., Breen, J., Rogasch, N., . . . Aidman, E. (2021). Mapping the genetic architectures of cognitive functioning. Poster session presented at the meeting of GeneMappers 2021. Virtual. |
| 2020 | Ciobanu, L., Schubert, O., Amare, A., Jawahar, C., Lawrence-Woods, E., Mills, N., . . . Aidman, E. (2020). P9. MAPPING THE GENETIC ARCHITECTURES OF COGNITIVE FITNESS: CAN GWAS DATA DIFFERENTIATE EXECUTIVE FUNCTIONING FROM GENERAL COGNITIVE ABILITY?. Poster session presented at the meeting of Nature Neurogenetics. New York. |
| 2019 | Baune, B., Sampson, E., Mills, N., Lyrtzis, E., Aboustate, N., Hori, H., . . . Fourrier, C. (2019). Vortioxetine with or without anti-inflammatory augmentation improves mood, cognition and functioning in MDD patients: results from the PREDDICT clinical trial. Poster session presented at the meeting of RANZCP. Hobart. |
| 2018 | Baune, B., Mills, N., Sampson, E., Aboustate, N., & Fourrier, C. (2018). Switching strategies for Vortioxetine in the PREDDICT Study. Poster session presented at the meeting of Biological Psychiatry Australia. Adelaide. |
| Year | Citation |
|---|---|
| 2024 | Amente, L. D., Mills, N., Le, T. D., Hyppönen, E., & Lee, H. (2024). A latent outcome variable approach for Mendelian randomization using the expectation maximization algorithm. DOI |
Associate Investigator (AI) of University of South Australia CHS Grant-in-Aid, $19,874 (2024)
Chief Investigator A (CIA) of University of Adelaide Faculty of Health and Medical Sciences (Adelaide Medical School) Building Research Leaders Award, $39,660 (2023)
CIL of University of Adelaide Research Infrastructure funding award 'EEG system to support Psychology and Neurosciences research’, $69,804 (2022)
CIA of University of Adelaide Faculty Emerging Leaders Development Award, $37,061 (2021)
Associate Investigator (AI) - MRFF Neurological Disorders Grant Opportunity - Does repetitive transcranial magnetic stimulation (rTMS), compared to sham rTMS, improve social communication in adolescents and young adults with autism spectrum disorder (ASD) $1,903,208 (2020 - 2024)
CIA of University of Adelaide Emerging Leadership Mentored Development Program, $39,115 (2019)
AI-D of Royal Adelaide Hospital Research Committee Clinical Project Grant $40,242 (2019)
CIB of Fay Fuller Foundation Discovery Grant, $327,000 (mid 2017- mid 2019)
CIA of Pfizer Neuroscience Research Grant $44,000 (2012)
CIA QIMR Berghofer Higher Degree Travel Committee Award $700 (2012)
CIA Australian Twin Registry Research Travel Grant $600 (2012)
CIA of Royal Australian and New Zealand College of Psychiatrists Young Investigator Grant $6,000 (2010)
Teaching and co-ordinator of University of Adelaide Year 4 MBBS Psychiatry course (since January 2020)
Teaching and co-convenor of University of Adelaide Year 4 MBBS Psychiatry course (August 2016 - December 2019)
Case-based learning tutor University of Adelaide Year 3 MBBS (semester 2, 2019)
Lecturer University of Adelaide, Biological Psychiatry course (2016 - 2024)
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2022 | Co-Supervisor | Application of statistical genomic methods to tackle heterogeneity in psychiatric diseases | Doctor of Philosophy | Doctorate | Full Time | Miss Caitlin Doyle |
| 2022 | Co-Supervisor | Novel statistical genomics methods for disentangling genetic architecture and causal pathways in cardiometabolic traits | Doctor of Philosophy | Doctorate | Full Time | Lamessa Amente |
| Date | Role | Research Topic | Location | Program | Supervision Type | Student Load | Student Name |
|---|---|---|---|---|---|---|---|
| 2022 - 2022 | Co-Supervisor | The association of anxiety symptom severity and panic attacks with inflammation | University of Adelaide | Psychology | Honours | - | Aylin Erginbas |
| 2019 - 2019 | Co-Supervisor | Inflammation and anxiety-based disorders in children and adolescents: a systematic review and meta-analysis | The University of Adelaide, School of Psychology | - | Honours | - | Chelsea Parsons |
| 2017 - 2017 | Co-Supervisor | Exploring the relationship between cognitive impairment and psychosocial functioning in Major Depressive Disorder | The University of Adelaide | Adelaide Medical School | Honours | - | Olivia Cambridge |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2025 - ongoing | Member | 2026 RANZCP Faculty of Child and Adolescent Psychiatry Conference Organising Committee | Adelaide University | Australia |
| 2025 - 2025 | Member | 2025 Society for Mental Health Research Conference Organising Committee | Adelaide University | Australia |
| 2023 - ongoing | Member | MRFF Grant Assessment Committee | University of Adelaide | Australia |
| 2022 - 2022 | Vice-Chair | Year 4 & 5 MBBS Written Exam Committee | University of Adelaide | Australia |
| 2021 - ongoing | Member | University of Adelaide Year 4 MBBS Written exam subcommittee | University of Adelaide | Australia |
| 2021 - ongoing | Member | University of Adelaide Year 4 MBBS OSCE Subcommittee | University of Adelaide | Australia |
| 2018 - ongoing | Member | Adelaide Medical School MBBS Research Committee | University of Adelaide | Australia |
| 2018 - ongoing | Member | Faculty Seminar Series Organising Committee | University of Adelaide | Australia |
| 2015 - 2015 | Member | Organising Committee 2015 Society for Mental Health Research Conference | Society for Mental Health Research | Australia |
| 2014 - 2015 | Member | Scientific Program Committee 2015 Royal Australian and New Zealand College of Psychiatrists Congress | Royal Australian and New Zealand College of Psychiatrists | Australia |
| 2014 - 2014 | Member | Organising Committee Royal Australian and New Zealand College of Psychiatrists Faculty of Child and Adolescent Psychiatry Conference | Royal Australian and New Zealand College of Psychiatrists | Australia |
| 2012 - 2012 | Member | Royal Australian and New Zealand College of Psychiatrists, Queensland Faculty of Child and Adolescent Psychiatry Conference Organising Committee | RANZCP | Australia |
| Date | Title | Engagement Type | Institution | Country |
|---|---|---|---|---|
| 2018 - 2018 | Radio interview | Scientific Community Engagement | QIMR Berghofer Medical Research Institute | - |
| Date | Office Name | Institution | Country |
|---|---|---|---|
| 2014 - 2016 | Child and Adolescent Psychiatrist | Royal Brisbane and Women's Hospital | Australia |
| 2012 - 2014 | Child and Adolescent Psychiatrist | Ipswich Hospital | Australia |
Connect With Me
External Profiles
